'Booming' China Pharma R&D Reaches New Peak

Landmark As Two Firms Enter Top 25

 
• By Brian Yang

China has emerged as a major new force in global pharma R&D amid a "boom" in activity, with not one but two of its companies entering the top 25 by pipeline size for the first time. 

China pharma companies taking off to be ranked among top 25 in R&D
CHINA PHARMA FIRMS TAKE OFF TO RANK IN TOP 25 WORLDWIDE • Source: Alamy

More from China

More from Focus On Asia